STAT5B and chronic myelogenous leukemia, BCR-ABL1 positive: Additionally, tetrahydroquinoline derivatives (Polomski et al., 2021) and taxodione (Uchihara et al., 2018) antagonized chronic myelocytic leukemia by inhibiting activation of STAT5 signaling.